Premium
Role of albiglutide in the treatment of type 2 diabetes
Author(s) -
Chaplin Steve
Publication year - 2016
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1471
Subject(s) - medicine , type 2 diabetes , diabetes mellitus , endocrinology
Albiglutide (Eperzan) is a GLP‐1 agonist licensed for the treatment of type 2 diabetes in adults to improve glycaemic control. This article discusses its indications, efficacy and adverse effects.